Structural role of disulfide bridges in the cyclic ADP‐ribose related bifunctional ectoenzyme CD38
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Human CD38, a type II cell surface glycoprotein, is a bifunctional ectoenzyme catalyzing both ADP‐ribosyl cyclase and cyclic ADP‐ribose (cADPR) hydrolase reactions. It shares a high degree of sequence homology with the cyclase from Aplysia species and studies of site‐directed mutagenesis have recently demonstrated the importance, but not elucidated the role, of several cysteine residues highly conserved between these proteins.N‐Ethylmaleimide, iodoacetamide and thiol‐oxidizing reagents failed to affect either the cyclase or the weaker hydrolase activity of the Aplysia californica protein. Likewise, these reagents did not impair the two activities of CD38 purified from human erythrocytes. β‐mercaptoethanol had no effect on the Aplysia enzyme activities, while it inactivated both the cyclase and the cADPR hydrolase of CD38 by inducing its extensive oligomerization. In intact erythrocytes the β‐mercaptoethanol‐dependent enzyme inactivation was completely prevented by prior cross‐linking of the membrane proteins with glutaraldehyde. These data demonstrate that none of the cysteine residues plays any direct catalytic role in CD38 and Aplysia proteins, and that disulfide bridges are essential for maintaining the monomeric, catalytically active structure of CD38.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jackson, D. G., & Bell, J. I. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.7.2811 · Cited by 343
Cited by
Connexin 43 hemichannels mediate Ca2+‐regulated transmembrane NAD+ fluxes in intact cells
Bruzzone, S., Guida, L., Zocchi, E., Franco, L., & Flora, A. D. (2001) · The FASEB Journal · doi:10.1096/fj.00-0566fje · Cited by 463
Human CD38, a cell‐surface protein with multiple functions
Mehta, K., Shahid, U., & Malavasi, F. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.12.8903511 · Cited by 295
Resolving the daratumumab interference with blood compatibility testing
Chapuy, C. I., Nicholson, R. T., Aguad, M. D., Chapuy, B., Laubach, J. P., Richardson, P. G., Doshi, P., & Kaufman, R. M. (2015) · Transfusion · doi:10.1111/trf.13069 · Cited by 239
“investigators reported that the enzymatic activity of CD38 was highly sensitive to reducing agents such as DTT(14) and 2-mercaptoethanol.(9) Berthelier and colleagues(8) reported that treating CD381 HL60 cells with DTT decreased the binding of specific MoAbs to CD38 by denaturing the protein.”
BackgroundMethodGaravaglia, S., Bruzzone, S., Cassani, C., Canella, L., Allegrone, G., Sturla, L., Mannino, E., Millo, E., De Flora, A., & Rizzi, M. (2012) · Biochemical Journal · doi:10.1042/bj20111263 · Cited by 94
Boslett, J., Hemann, C., Christofi, F. L., & Zweier, J. L. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2017 · Cited by 65
“One possibility is modulation of one or more of the six disulfide bonds in the catalytic domain of CD38 (30), which have been shown to be important for CD38 activity (23, 42, 51).”
Background
Metadata
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1995-07-24
- Volume
- 368
- Issue
- 3
- Pages
- 481-484
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2003353539
- Cited by
- 65
- References
- 1
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural role of disulfide bridges in the cyclic ADP‐ribose related bifunctional ectoenzyme CD38. https://app.cochat.ai/papers/10.1016/0014-5793(95)00715-l
- The paper
- Structural role of disulfide bridges in the cyclic ADP‐ribose related bifunctional ectoenzyme CD38. (1995). FEBS Letters. https://doi.org/10.1016/0014-5793(95)00715-l
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.